Transcend Public Benefit Corporation Launches $20 Million Initiative for Psychedelic Mental Health Research and Access
Transcend Public Benefit Corporation is allocating approximately $20 million over the next year to support nonprofit organizations in advancing psychedelic mental health care research, access, and infrastructure. The initiative aligns with Transcend Therapeutics' recent acquisition and aims to address gaps for underserved populations such as trauma survivors, LGBTQ+ individuals, and those dealing with addiction or depression.
Topics: corporate philanthropy mental health nonprofits psychedelic therapeutics